Sedonil Tablet 3mg: A Reliable Solution for Severe Anxiety
Sedonil Tablet 3mg is a short-term medication designed to treat severe anxiety symptoms. It is particularly useful for individuals experiencing heightened anxiety, either with or without insomnia. This central nervous system depressant helps induce a sense of calm, tiredness, and sleep by enhancing the activity of GABA, an inhibitory neurotransmitter that binds to specific GABA receptors across the CNS.
Uses
- Severe Anxiety: Sedonil is prescribed for the short-term treatment of severe anxiety, providing relief for individuals dealing with intense anxiety symptoms.
- Anxiety with Insomnia: It is specifically designed to address symptoms of severe anxiety that occur either with or without insomnia, helping to alleviate sleep disturbances associated with anxiety.
- Insomnia Relief: Sedonil can aid in improving sleep patterns by addressing insomnia linked to severe anxiety.
Side Effects
Some common side effects include:
- Dizziness.
- Muscle Weakness.
- Ataxia (Loss of Muscle Control).
- Vertigo (Head-Spinning).
- Confusion.
- Gastro-Intestinal Upset.
- Visual Disturbance.
- Skin Rash.
- Decreased Alertness.
- Headache.
Precautions
- Long-term Use: Use caution when treating long-term respiratory problems.
- Health Conditions: Individuals with myasthenia gravis, damaged kidneys and liver, and a history of alcohol use should avoid using Sedonil.
- Advanced Ages and Personality Issues: Patients with personality issues and advanced ages should be treated with caution.
When Not to Use
This medication is not recommended for individuals with:
- Respiratory system insufficiencies and diseases.
- Sleep disruptions.
- Phobias.
- Psychological problems.
- Unstable myasthenia gravis.
- Kidney and liver dysfunction.
Pregnancy and Lactation
For accurate analysis, consult your doctor before using Sedonil during pregnancy or breastfeeding.
Price
Sedonil Tablet 3mg is available for Rs 61 in Pakistan. For a pack of 30 tablets, the price is Rs 130.83.
Reviews
There are no reviews yet.